Peter Arduini Net Worth

The estimated Net Worth of Peter J Arduini is at least $22.4 millió dollars as of 2 September 2021. Mr. Arduini owns over 118,434 units of Integra Lifesciences Corp stock worth over $4,634,397 and over the last 20 years he sold IART stock worth over $9,906,594. In addition, he makes $7,859,420 as President, Chief Executive Officer és Director at Integra Lifesciences Corp.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Arduini IART stock SEC Form 4 insiders trading

Peter has made over 30 trades of the Integra Lifesciences Corp stock since 2008, according to the Form 4 filled with the SEC. Most recently he exercised 118,434 units of IART stock worth $2,472,902 on 2 September 2021.

The largest trade he's ever made was exercising 250,000 units of Integra Lifesciences Corp stock on 6 September 2019 worth over $3,472,500. On average, Peter trades about 7,436 units every 47 days since 2005. As of 2 September 2021 he still owns at least 263,318 units of Integra Lifesciences Corp stock.

You can see the complete history of Mr. Arduini stock trades at the bottom of the page.

Peter Arduini biography

Peter J. Arduini serves as President, Chief Executive Officer, Director of the Company. He joined Integra in November 2010 as President and Chief Operating Officer and was appointed Chief Executive Officer and a director in January 2012. Before joining Integra, Mr. Arduini was corporate vice president and president of Medication Delivery, Baxter Healthcare, from 2005 to 2010. Mr. Arduini was responsible for a $4.8 billion global division of Baxter focused on inpatient pharmaceuticals and devices. Prior to that, he worked for 15 years in a variety of management roles for domestic and global business for General Electric Healthcare, culminating in leading the global functional imaging business. Mr. Arduini currently serves on the board of directors of Bristol-Myers Squibb Company, where he is a member of the audit committee and the compensation and management development committee. He serves on the board of directors of ADVAMED, the Advanced Medical Technology Association, the Medical Device Innovation Consortium, and the National Italian American Foundation. He also serves on the board of trustees of Susquehanna University. Mr. Arduini received his bachelor’s degree in marketing from Susquehanna University and a master’s in management from Northwestern University’s Kellogg School of Management.

What is the salary of Peter Arduini?

As the President, Chief Executive Officer és Director of Integra Lifesciences Corp, the total compensation of Peter Arduini at Integra Lifesciences Corp is $7,859,420. There are no executives at Integra Lifesciences Corp getting paid more.

How old is Peter Arduini?

Peter Arduini is 55, he's been the President, Chief Executive Officer és Director of Integra Lifesciences Corp since 2012. There are 11 older and 10 younger executives at Integra Lifesciences Corp. The oldest executive at Integra Lifesciences Holdings Corp is Dr. Richard E. Caruso, 78, who is the Founder and Chairman Emeritus.

What's Peter Arduini's mailing address?

Peter's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543.

Insiders trading at Integra Lifesciences Corp

Over the last 22 years, insiders at Integra Lifesciences Corp have traded over $397,927,161 worth of Integra Lifesciences Corp stock and bought 132,879 units worth $4,504,827 . The most active insiders traders include Neal Moszkowski, Stuart Essig és George Soros. On average, Integra Lifesciences Corp executives and independent directors trade stock every 19 days with the average trade being worth of $668,131. The most recent stock trade was executed by Jeffrey Mosebrook on 19 August 2024, trading 1,191 units of IART stock currently worth $25,702.

What does Integra Lifesciences Corp do?

integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li

Complete history of Mr. Arduini stock trades at Integra Lifesciences Corp, Baxter International, Bristol-Myers Squibb Co és GE Aerospace

Integra Lifesciences Corp executives and stock owners

Integra Lifesciences Corp executives and other stock owners filed with the SEC include:

• Peter Arduini,
  President, Chief Executive Officer, Director
• Glenn Coleman,
  Chief Operating Officer, Executive Vice President
• Carrie Anderson,
  Chief Financial Officer, Executive Vice President
• Eric Schwartz,
  Executive Vice President, Chief Legal Officer, Secretary
• Robert Davis,
  Executive Vice President, President - Orthopedics and Tissue Technologies
• Glenn G. Coleman,
  Exec. VP & COO
• Carrie L. Anderson,
  Exec. VP, CFO & Treasurer
• Robert T. Davis Jr.,
  Exec. VP and Pres of Orthopedics & Tissue Technologies
• Stuart Essig,
  Independent Chairman of the Board
• Rhonda Ballintyn,
  Independent Director
• Barbara Hill,
  Independent Presiding Director
• Christian Schade,
  Independent Director
• Donald Morel,
  Independent Director
• Lloyd Howell,
  Independent Director
• Keith Bradley,
  Independent Director
• Raymond Murphy,
  Independent Director
• Michael Beaulieu,
  IR Contact Officer
• Jeffrey Mosebrook,
  Senior Vice President, Principal Accounting Officer
• Michael McBreen,
  Executive Vice President and President - Codman Specialty Surgical
• Lisa Evoli,
  Executive Vice President, Chief Human Resources Officer
• Eric Ian Schwartz,
  Exec. VP, Chief Legal Officer & Sec.
• William Compton,
  Chief Information Officer & Sr. VP
• Dr. Kenneth E. Burhop Ph.D.,
  Corp. VP & Chief Scientific Officer
• Jeffrey Mosebrook,
  Sr. VP, Principal Accounting Officer & Corp. Controller
• Dr. Richard E. Caruso,
  Founder and Chairman Emeritus
• Jan De Witte,
  Pres, CEO & Director
• James M Sullivan,
  Director
• John Mooradian,
  Corp VP, Global Ops & Supp Chn
• Judith Ogrady,
  CorpVP,Global Reg.Affairs
• Kenneth Burhop,
  CORPVP,CHIEFSCIENTIFIC OFFICER
• Mark A Augusti,
  CVP,PRES-ORTHO & TISSUE TECH
• Richard D. Gorelick,
  Corp VP, Gen Counsel & Sec
• Harvinder Singh,
  EVP & PRESIDENT, INTERNATIONAL
• Chantal Veillon Berteloot,
  EVP & CHRO
• Richard E Caruso,
  10% owner
• Witte Jan De,
  President & CEO
• Joseph Vinhais,
  Corp VP,Quality&Transformation
• George Soros,
  10% owner
• David B Holtz,
  Sr. VP, Finance
• David C Auth,
  Director
• Don R Nociolo,
  Senior V.P., Operations
• Michael Piershbacher,
  Senior VP, Research & Dev.
• Maureen B Bellantoni,
  Exec V.P./CFO
• Neal Moszkowski,
  Director
• Anne Vanlent,
  Director
• Thomas J Jr Baltimore,
  Director
• Daniel L. Reuvers,
  CVP,PRES - CODMAN SPC SURGICAL
• Deborah A Leonetti,
  Senior VP, Marketing
• Padma Thiruvengadam,
  Corp VP, Chief HR Officer
• Robert D Paltridge,
  Sr. VP, Global Sales
• Gerard S Carlozzi,
  Exec. V.P., COO
• Brian Larkin,
  Corp VP, Pres.Gbl Spine &Ortho
• John B Iii Henneman,
  Exec. V.P., CAO, & Secretary
• Jerry E Corbin,
  VP & Corporate Controller
• St Partnership, L.P. Tru,
  10% owner
• Jeffrey A Graves,
  Director
• Renee Wonlai Lo,
  Director
• Lea Daniels Knight,
  EVP & CHIEF FINANCIAL OFFICER